Extrait

The purpose of this study is to evaluate the efficacy, safety and tolerability of PF-06649751 in Parkinson's disease patients at early stage of the disease.

Critère d'inclusion

• Parkinson disease

Pays

• France
• Germany
• Israel
• United States

Liens

• nct